Mark Griffin
AUTHOR

Mark Griffin

Mystery, Thriller & Suspense
Tap the gear icon above to manage new release emails.
In April 2017, Mark was short-listed in the top five out of three and a half thousand entrants in a national crime thriller writing competition sponsored by Random House Publishing for his debut novel, When Darkness Calls, (released 2018) which was nominated for the prestigious John Creasy Blood Dagger Award. His third book Silent Death (When Silence Kills) was short-listed for the thriller of 2022 in Germany. When Darkness Calls was the first book in a series starring criminal psychologist Holly Wakefield and DI Bishop of the Metropolitan Police. Little Brown Books in the UK acquired world English rights for the first four books from Mark, his debut and its sequel When Angels Sleep (released March 2019), book three, When Silence Kills (released August 2021) and book four, When Evil Wakes (release date August 2022) through Luigi Bonomi at LBA Books. German rights for the same four books were pre-empted by Harper Collins Germany via Nicki Kennedy at ILA which is handling all translation rights. As well as plays and numerous screenplays, Mark is now working on the next six books in the Holly Wakefield series for the same publishers reaching the UK, Europe and the North American Markets where all of Mark’s books are now available. He is now completing three stand-alone series: Dreamweaver (YA fantasy adventure), 1886 (a Victorian thriller set in London two years before the notorious Jack The Ripper cases) and The Autumn People (a horror novel set in a Cornish village).
Read more Read less

Best Sellers

Product List
  • Silent Death - Du entkommst mir nicht cover art

    Regular price: ₹300.00

    Free with 30-day trial
  • Dark Call - Du wirst mich nicht finden cover art

    Regular price: ₹367.00

    Free with 30-day trial
  • White Sleep - Unschuldig in den Tod cover art

    Regular price: ₹200.00

    Free with 30-day trial
  • Fürchte das Böse cover art

    Regular price: ₹401.00

    Free with 30-day trial